glp 1 amylin Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus ADA 2026 - Spatiocellular mapping

These are not random or unrelated

And when it works, it works well

An integrated benefit-risk assessment of cobalt-containing alloys used in medical devices: Implications for regulatory requirements in the European Union

Eng et al., J Biol Chem, 1992 Parkes et al., Diabetes Care, 2013 #GLP1 #DrugDiscovery #FromBenchToBedside #NephMadness #MedicalEducation #Endocrinology #Nephrology To view or add a comment, sign in More Relevant Posts Medicos quick Platelets MCQ

The booming online market for GLP-1s is giving people cheaper access to weight-loss drugs, but often without regulation or medical guidance

Has 3 Utility Model Patents, 1 Invention Patent